Locations:
SearchAdvertisement
Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers
Data from combined prospective and retrospective cohorts support the drug’s safety and efficacy for CLVM
Efficacy, safety and tolerability data shared at hematology meeting
New guidelines expand on psychosocial, sexual health, cognitive and other issues
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Consensus conference begins work on new recommendations for clinical care and research
Genetic changes are similar between some vascular anomalies and cancers
How to combat the rise in mortality when patients become adults
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients
Two-year event-free survival comparable to matched sibling donor myeloablative transplant
First-in-human trials of CRISPR-Cas12a gene editing demonstrate safety and meaningful event-free survival
Advertisement
Advertisement